Products 7448-03-5

CAS 7448-03-5 is the registry number for 4α-Methylzymosterol. Offered by: TRC. Available pack sizes: 10mg.

4α-Methylzymosterol
TRC
  • size: 10mg
  • Variants: 1
View product
Structural formula: {0} (CAS {1})

4alpha-methylzymosterol is a 3beta-sterol that is zymosterol substituted by a 4alpha-methyl group. It has a role as a mouse metabolite, a Saccharomyces cerevisiae metabolite and a human metabolite. It is a 3beta-sterol and a cholestanoid. It is functionally related to a zymosterol.

Source: ChEBI

Identity
Molecular formulaC28H46O
Molecular weight398.7 g/mol
IUPAC name(3S,4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyFOUJWBXBKVVHCJ-YIJYGBTNSA-N
SMILESC[C@H]1[C@@H]2CCC3=C([C@]2(CC[C@@H]1O)C)CC[C@]4([C@H]3CC[C@@H]4[C@H](C)CCC=C(C)C)C

Computed by PubChem (NCBI)

Synonyms: 4alpha-Methylzymosterol, 4alpha-methyl-5alpha-cholesta-8,24-dien-3beta-ol, 4a-Methylzymosterol, 4-methyl-8,24-cholestadienol, 4a-methyl-5a-cholesta-8,24-dien-3b-ol, (3b,4a,5a)-4-methylcholesta-8,24-dien-3-ol, 4-alpha-methyl-5alpha-cholesta-8,24-dien-3beta-ol, 4I+--Methylzymosterol, 4alpha-Methyl-delta8,24-cholestenol, 4I+--Methyl-5I+--cholesta-8,24-dien-3I2-ol
Isomers (same molecular formula)
(3S,9S,10R,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5S)-5,6-dimethylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C28H46O
(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-methylidene-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
trans-(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol C28H46O
(4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C28H46O
4,10,13-trimethyl-17-(6-methylheptan-2-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C28H46O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O